A company insider recently sold 8,009 shares of Resmed Inc [RMD]. Should You also Consider to Sale?

Resmed Inc’s recently made public that its Chief Executive Officer Farrell Michael J. unloaded Company’s shares for reported $2.23 million on Sep 08 ’25. In the deal valued at $278.14 per share,8,009 shares were sold. As a result of this transaction, Farrell Michael J. now holds 467,792 shares worth roughly $128.93 million.

Then, Farrell Michael J. bought 8,009 shares, generating $2,227,591 in total proceeds.

Before that, Sandercock Brett sold 3,000 shares. Resmed Inc shares valued at $812,310 were divested by the Chief Financial Officer at a price of $270.77 per share. As a result of the transaction, Sandercock Brett now holds 87,745 shares, worth roughly $24.18 million.

Citigroup initiated its Resmed Inc [RMD] rating to a Buy in a research note published on September 18, 2025; the price target was $330. A number of analysts have revised their coverage, including CLSA’s analysts, who increased its forecast for the stock in early September from “a Hold” to “an Outperform”. RBC Capital Mkts also remained covering RMD and has increased its forecast on July 15, 2025 with a “an Outperform” recommendation from previously “Sector perform” rating. Morgan Stanley started covering the stock on March 19, 2025. It rated RMD as “an Overweight”.

Price Performance Review of RMD

On Tuesday, Resmed Inc [NYSE:RMD] saw its stock jump 0.44% to $275.61. Over the last five days, the stock has gained 1.10%. Resmed Inc shares have risen nearly 13.43% since the year began. Nevertheless, the stocks have risen 20.52% over the past one year. While a 52-week high of $293.81 was reached on 08/22/25, a 52-week low of $199.92 was recorded on 04/07/25.

Levels Of Support And Resistance For RMD Stock

The 24-hour chart illustrates a support level at 273.54, which if violated will result in even more drops to 271.48. On the upside, there is a resistance level at 277.39. A further resistance level may holdings at 279.17.

How much short interest is there in Resmed Inc?

A steep rise in short interest was recorded in Resmed Inc stocks on 2025-08-29, dropping by -0.51 million shares to a total of 8.51 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-31 was 9.02 million shares. There was a decline of -5.98%, which implies that there is a negative sentiment for the stock.

The most recent change occurred on March 19, 2025 when Morgan Stanley began covering the stock and recommended ‘”an Overweight”‘ rating.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.